Home > 产品 > Other products


Synthetic description of the product:WF11899Ais the intermediates of Micafungin. Micafungin (trade name Mycamine) is an echinocandin antifungal drug developed by Astellas Pharma. It inhibits the production of beta-1,3-glucan, an essential component of fungal cell walls. Micafungin is administered intravenously. It received final approval from the U.S. Food and Drug Administration on March 16, 2005, and gained approval in the European Union on April 25, 2008.

Product Name: WF11899A

Structural formula
Synonyms:
chemical name:5-[(9aR)-9-({(2S)-1-[(2S,3R)-2-{[(2S)-5-amino-2-(hexadecanoylamino)-4,5-dihydroxypentanoyl]amino}-3-hydroxybutanoyl]-4-hydroxypyrrolidin-2-yl}carbonyl)-9a-[(2S,3R)-2-amino-3-hydroxybutanoyl]-3-(2-amino-2-oxoethyl)-3,8,9-trihydroxy-7-methyl-1,5-dioxooctahy
CAS:160335-87-5
Molecular Formula:C51H82N8O21S
Molecular Weight:1175.3028
 

                   PRODUCT SPECIFICATIONS             ||                          DATA PROCESS SUMMARY

Appearance
  drying shrinkage  
Assay   Water  
impurity      
heavy metal      
Residue on ignition      
Content      
 
 
   MAIN RAW MATERIAL for FERMENTATION    ||             MAIN RAW MATERIAL for RECOVERY

quality standard
  packing specification  
product certification   Outside the bag material  
quality guarantee period   Other  
       
 
 
DSP – BLOCK DIAGRAM 

产品